Zhou Yanyan, Wang Lei, Liu Yuchen, Fan Lili, Zhang Xueying, Shi Qingru, Li Xulu, Lin Yining, Wu Feihua
School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.
J Pharm Pharmacol. 2023 Dec 8;75(12):1530-1543. doi: 10.1093/jpp/rgad087.
The activation of store-operated calcium entry (SOCE) channel and endoplasmic reticulum stress (ERS) induced by high glucose (HG) is recognized as a major cause of vascular endothelial dysfunction. This study aims to investigate the protective effect of homoplantaginin (Hom) on HG-induced endothelial dysfunction.
HG-induced vascular endothelial dysfunction model in human umbilical vein endothelial cells (HUVECs) and rat-isolated thoracic aortas were established to observe the protective effect of Hom, further evaluated the mechanism of SOCE channel and ERS in the pathogenesis.
Hom increased the levels of nitric oxide (NO) and phospho-endothelial nitric oxide synthase (p-eNOS) in HUVECs and isolated rat thoracic aortas in a dose-dependent manner, restored acetylcholine-mediated endothelium-dependent vasodilation. Network pharmacology showed that the pathogenesis of diabetic vascular complications may involve calcium (Ca2+) signal pathway. Hom reduced Ca2+ concentration via blocking SOCE channel in HUVECs, and resisted ERS activation by down-regulating ERS-related proteins expression. Importantly, SKF96365 (SOCE inhibitor) intervention experiment showed that Hom inhibited ERS activation by blocking the SOCE channel, further increased the levels of NO and p-eNOS.
Hom could alleviate HG-induced vascular endothelial dysfunction by inhibiting SOCE channel and ERS. This provided a potential pharmacological intervention strategy for the treatment of vascular endothelial dysfunction.
高糖(HG)诱导的钙库操纵性钙内流(SOCE)通道激活和内质网应激(ERS)被认为是血管内皮功能障碍的主要原因。本研究旨在探讨高车前素(Hom)对HG诱导的内皮功能障碍的保护作用。
建立HG诱导的人脐静脉内皮细胞(HUVECs)和大鼠离体胸主动脉血管内皮功能障碍模型,观察Hom的保护作用,进一步评估SOCE通道和ERS在发病机制中的作用。
Hom以剂量依赖的方式增加HUVECs和离体大鼠胸主动脉中一氧化氮(NO)和磷酸化内皮型一氧化氮合酶(p-eNOS)的水平,恢复乙酰胆碱介导的内皮依赖性血管舒张。网络药理学表明,糖尿病血管并发症的发病机制可能涉及钙(Ca2+)信号通路。Hom通过阻断HUVECs中的SOCE通道降低Ca2+浓度,并通过下调ERS相关蛋白表达抵抗ERS激活。重要的是,SKF96365(SOCE抑制剂)干预实验表明,Hom通过阻断SOCE通道抑制ERS激活,进一步增加NO和p-eNOS水平。
Hom可通过抑制SOCE通道和ERS减轻HG诱导的血管内皮功能障碍。这为治疗血管内皮功能障碍提供了一种潜在的药理学干预策略。